Published in Clin Immunol Immunopathol on June 01, 1983
Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest (1984) 1.11
Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus. Clin Exp Immunol (1986) 1.01
Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction. Clin Exp Immunol (1985) 0.89
Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease. Clin Exp Immunol (1992) 0.86
Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis. Eur J Med Res (2010) 0.80
Human cell-mediated immune responses to antigenic fractions of Salmonella typhi. Immunology (1996) 0.79
Response of T-cell subpopulations to superantigen and recall antigen stimulation in systemic sclerosis. Indian J Dermatol (2012) 0.75
Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.75
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Ann Rheum Dis (2007) 3.31
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med (1995) 2.89
On the catastrophic adjective for the antiphospholipid syndrome. Clin Exp Rheumatol (1994) 2.68
Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature (1978) 1.91
Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function. J Immunol (1979) 1.63
Erythermalgia, erythromelalgia, or both? Conditions neglected by rheumatologists. J Rheumatol (1993) 1.42
Cellular immune response to fractionated avian antigens by peripheral blood mononuclear cells from patients with pigeon breeder's disease. J Lab Clin Med (1996) 1.39
Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum (1978) 1.20
Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Clin Exp Immunol (1985) 1.18
Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology (1996) 1.14
Receptor and non-receptor-bearing lymphocytes in untreated systemic lupus erythematosus. Variations with disease activity. Rev Invest Clin (1978) 1.11
Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus (2005) 1.09
Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum (1997) 1.09
How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol (1993) 1.04
T-lymphocyte subpopulation in untreated SLE. Variations with disease activity. Arthritis Rheum (1977) 1.03
Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) (1996) 1.02
C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE. J Rheumatol (1981) 1.02
Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus. Clin Exp Immunol (1986) 1.01
Symptomatic Sjögren's syndrome in mixed connective tissue disease. J Rheumatol (1976) 0.99
Long-term treatment of symptomatic osteoarthritis with benoxaprofen. Double-blind comparison with aspirin and ibuprofen. J Rheumatol Suppl (1980) 0.97
Resistance to Nocardia brasiliensis infection in mice immunized with either Nocardia or BCG. Mycopathologia (1980) 0.97
Descriptions of therapeutic arthrocenthesis and of synovial fluid in a Nahuatl text from prehispanic Mexico. Ann Rheum Dis (1980) 0.96
Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels. J Immunol (1997) 0.96
Antibodies to histones in systemic lupus erythematosus. Clin Exp Immunol (1979) 0.95
Mixed connective tissue disease - a decade of growing pains. J Rheumatol (1982) 0.93
Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction. Clin Exp Immunol (1985) 0.89
Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest (1990) 0.89
The connective tissue diseases as disorders of immune regulation. Clin Rheum Dis (1985) 0.89
Antibody penetration into living cells. III. Effect of antiribonucleoprotein IgG on the cell cycle of human peripheral blood mononuclear cells. Clin Immunol Immunopathol (1982) 0.88
The effect of formalin fixation on the polymerase chain reaction characterization of Entamoeba histolytica. Trans R Soc Trop Med Hyg (1999) 0.88
Nocardia brasiliensis: mycetoma induction and growth cycle. Infect Immun (1982) 0.87
Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. J Rheumatol (1981) 0.86
Case report: erythermalgia in systemic lupus erythematosus. Am J Med Sci (1973) 0.86
Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol (1980) 0.86
Abnormal esophageal motility in primary Sjögren's syndrome. J Rheumatol (1976) 0.85
Erythermalgia. A clue to the early diagnosis of myeloproliferative disorders. Arch Intern Med (1966) 0.85
Mononuclear cell-fibroblast interactions in scleroderma. Clin Immunol Immunopathol (1988) 0.84
Changes in host resistance caused by Nocardia brasiliensis in mice: cross-protection against Listeria monocytogenes. Int Arch Allergy Appl Immunol (1978) 0.84
Leg ulcers in the primary antiphospholipid syndrome. Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol (1991) 0.83
Splenectomy for hemocytopenia in systemic lupus erythematosus. A controlled appraisal. Arch Intern Med (1979) 0.83
The heterogeneity of anti-DNA antibodies in systemic lupus erythematosus and other diseases. J Rheumatol (1975) 0.83
The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Am J Med (1996) 0.82
Anti-E. histolytica IgA antibodies in saliva of E. histolytica or E.dispar infected individuals: longitudinal study of cohorts. Arch Med Res (1997) 0.82
Persistence of secretory antiamoebic antibodies in patients with past invasive intestinal or hepatic amoebiasis. Parasitol Res (2001) 0.82
Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease. J Rheumatol (1977) 0.82
Reincidence of amebic liver abscess: a case report. Arch Med Res (2000) 0.82
Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family. J Rheumatol (1978) 0.82
Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus. J Autoimmun (1994) 0.81
Salivary gland involvement in diseases associated with Sjögren's syndrome. 1. Radionuclide & roentgenorgraphic studies. J Rheumatol (1974) 0.81
Development of sicca symptoms in systemic lupus erythematosus patients with existing subclinical abnormalities of lacrimal and/or salivary glands. Arthritis Rheum (1979) 0.81
Inhibition of adhesion process mediated by anti-Entamoeba histolytica specific monoclonal IgA antibodies. Arch Med Res (1992) 0.81
Entamoeba histolytica: specific antigen recognized by a monoclonal antibody. Exp Parasitol (1986) 0.81
HLA class I and class II alleles and haplotypes in Mexican mestizos established from serological typing of 50 families. Hum Biol (1997) 0.80
Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol (1977) 0.80
Defects of the retinal pigment epithelium in scleroderma. Br J Rheumatol (1991) 0.80
Periodicity and patterns of Entamoeba histolytica and E. dispar infection in HIV+/AIDS patients in Mexico. Ann Trop Med Parasitol (2009) 0.80
[Generalized lupus erythematosus with agranulocytosis and hemolytic anemia caused by drugs]. Prensa Med Mex (1971) 0.80
Chronic interstitial cystitis as an initial major manifestation of systemic lupus erythematosus. J Rheumatol (1982) 0.80
T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin Immunol Immunopathol (1986) 0.79
The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. Arthritis Rheum (1989) 0.79
Esophageal motility in systemic lupus erythematosus. Am J Dig Dis (1974) 0.79
Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: the difference from systemic lupus erythematosus. Lupus (1995) 0.79
Prevalence of Entamoeba histolytica and Entamoeba dispar in a highly endemic rural population. Arch Med Res (2000) 0.79
Human cell-mediated immune responses to antigenic fractions of Salmonella typhi. Immunology (1996) 0.79
Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population. J Rheumatol (1981) 0.78
Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases. J Rheumatol (1978) 0.78
Entamoeba histolytica: antibody response to recent and past invasive events. Ann Trop Med Parasitol (1993) 0.78
Immunoglobulin heavy chain constant-region gene polymorphism in systemic lupus erythematosus. Arthritis Rheum (1991) 0.78
Cimetidine abrogates suppressor T cell function in vitro. Immunol Lett (1981) 0.78
Electrically induced release of (3H)5-hydroxytryptamine from neocortical slices in vitro: influence of calcium but not of lithium ions. Brain Res (1975) 0.78
Sjögren's syndrome in Behçet's disease. Lancet (1973) 0.78
Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone. Clin Exp Immunol (1982) 0.77
Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients of patients with PSS. Arthritis Rheum (1977) 0.77
Immunologic studies in patients with Takayasu's arteritis. III. Immunoregulatory changes. Clin Exp Rheumatol (1990) 0.77
Mixed connective tissue disease. Appearance of antibodies to ribonucleoprotein following corticosteroid treatment. J Rheumatol (1980) 0.77
Lupus hair. Am J Med Sci (1974) 0.77
Echocardiographic evaluation of patients with rheumatoid arthritis. Clin Rheumatol (1983) 0.76
Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998. Semin Arthritis Rheum (1999) 0.76
Entamoeba histolytica adherence: inhibition by IgA monoclonal antibodies. Adv Exp Med Biol (1995) 0.76
Protein-caloric malnutrition and systemic lupus erythematosus. J Rheumatol (1980) 0.76
HLA characterization in adult asymptomatic cyst passers of Entamoeba histolytica/E. dispar. Parasitol Res (1999) 0.76
Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C deficiencies. Am J Hematol (1993) 0.76
Effect of the new immunoregulator AS-101 on in vitro functions of mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1989) 0.75
Survival of Mexican patients with systemic lupus erythematosus. Rheumatology (Oxford) (2001) 0.75
Humoral immune response against Salmonella typhimurium antigen fractions and protection. Adv Exp Med Biol (1995) 0.75
Local and systemic antibody response in Balb/c mice immunized with Entamoeba histolytica trophozoites. Arch Med Res (1992) 0.75
[Use of corticosteroids in rheumatology (author's transl)]. Rev Invest Clin (1978) 0.75
Western blot of Entamoeba histolytica antigenic fractions: reactivity analysis with sera from intestinal amoebiasis patients. Ann Trop Med Parasitol (1992) 0.75
T lymphocyte subsets, suppressor and contrasuppressor cell functions, and production of interleukin-2 in the peripheral blood of rheumatic fever patients and their apparently healthy siblings. Clin Immunol Immunopathol (1990) 0.75
[Fecal and serum anti-amebic antibodies in acute intestinal amebiasis]. Arch Invest Med (Mex) (1990) 0.75
Human post-thymic precursor cells in health and disease. V. Stimulatory effect of serum thymic factor on the cell cycle of autologous-rosette forming and T gamma-cells. Immunol Lett (1982) 0.75
Specific anti-E. histolytica IgA monoclonal antibodies. Adv Exp Med Biol (1995) 0.75
A defect in immunoregulatory synovial fluid T cells in Behçet's syndrome. Clin Rheumatol (1989) 0.75
[Suppressor activity in the immune system (author's transl)]. Rev Med Chil (1979) 0.75
Serum IgA deficiency induced by prolonged phenytoin treatment. Rev Invest Clin (1990) 0.75
Repigmentation of vitiligo under penicillamine therapy for rheumatoid arthritis. Arch Dermatol (1982) 0.75
Antilymphocytic antibodies in mixed connective tissue disease. Arthritis Rheum (1983) 0.75
Retrocardiac mass: a clue to the tuberculous nature of monarthritis. Arthritis Rheum (1980) 0.75